DYNAVAX TECHNOLOGIES

dynavax-technologies-logo

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018TM adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

#SimilarOrganizations #People #Financial #Event #Website #More

DYNAVAX TECHNOLOGIES

Social Links:

Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical Device

Founded:
1996-01-01

Address:
Berkeley, California, United States

Country:
United States

Website Url:
http://www.dynavax.com

Total Employee:
501+

Status:
Active

Contact:
+1 510 848 1327

Email Addresses:
[email protected]

Total Funding:
1.04 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online


Similar Organizations

vero-biotech-logo

Vero Biotech

Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.

inventiva-pharma-logo

Inventiva Pharma

Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

aptose-biosciences-logo

Aptose Biosciences

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class

triomed-innovations-logo

TrioMed Innovations

TrioMed Innovations develops antimicrobial technologies and products to prevent the spreading of infections and diseases.

vygon-logo

Vygon

Vygon offer health professionals efficient and innovative single-use medical products adapted to their needs.


Current Advisors List

julie-eastland_image

Julie Eastland Board Member / Audit Committe Chair @ Dynavax Technologies
Board_member
2020-08-01

arnie-oronsky_image

Arnie Oronsky Board of Directors @ Dynavax Technologies
Board_member

david-lawrence_image

David Lawrence Member of the Board of Directors @ Dynavax Technologies
Board_member

albert-cha_image

Albert Cha Investor @ Dynavax Technologies
Board_member

laura-a-brege_image

Laura A. Brege Member of Board of Directors @ Dynavax Technologies
Board_member
2015-02-01

jan-leschly_image

Jan Leschly Board Member @ Dynavax Technologies
Board_member

not_available_image

Dennis Carson Board Member @ Dynavax Technologies
Board_member

not_available_image

Peter Paradiso Board of Directors @ Dynavax Technologies
Board_member

Current Employees Featured

michael-ostrach_image

Michael Ostrach
Michael Ostrach Finance and Legal Consultant @ Dynavax Technologies
Finance and Legal Consultant
2021-04-01

eddie-gray_image

Eddie Gray
Eddie Gray Director & CEO @ Dynavax Technologies
Director & CEO

ryan-spencer_image

Ryan Spencer
Ryan Spencer CEO @ Dynavax Technologies
CEO

not_available_image

Dennis Carson
Dennis Carson Co-Founder @ Dynavax Technologies
Co-Founder

david-novack_image

David Novack
David Novack President and COO @ Dynavax Technologies
President and COO

robert-l-coffman_image

Robert L. Coffman
Robert L. Coffman SVP & CSO @ Dynavax Technologies
SVP & CSO

Founder


not_available_image

Dennis Carson

Stock Details


Company's stock symbol is NASDAQ:DVAX

Acquisitions List

Date Company Article Price
2009-11-10 Symphony Dynamo Symphony Dynamo acquired by Dynavax Technologies N/A

Investors List

coalition-for-epidemic-preparedness-innovations-cepi_image

Coalition for Epidemic Preparedness Innovations

Coalition for Epidemic Preparedness Innovations investment in Post-IPO Debt - Dynavax Technologies

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Grant - Dynavax Technologies

the-capital-royalty-fund_image

CRG

CRG investment in Post-IPO Debt - Dynavax Technologies

herculescapital_image

Hercules Capital

Hercules Capital investment in Debt Financing - Dynavax Technologies

national-institute-of-allergy-and-infectious-diseases_image

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases investment in Grant - Dynavax Technologies

deerfield_image

Deerfield

Deerfield investment in Post-IPO Debt - Dynavax Technologies

alta-partners_image

Alta Partners

Alta Partners investment in Series D - Dynavax Technologies

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Series D - Dynavax Technologies

care-capital_image

Care Capital

Care Capital investment in Series D - Dynavax Technologies

forward-ventures_image

Forward Ventures

Forward Ventures investment in Series D - Dynavax Technologies

Official Site Inspections

http://www.dynavax.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K

  • Host name: ec2-34-192-255-123.compute-1.amazonaws.com
  • IP address: 34.192.255.123
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Dynavax Technologies" on Search Engine